Back

Dementia in patients with type 2 diabetes: a nationwide Danish study

30 August 2026 (14:40 - 14:50)
Organised by: Logo
Congress Presentation Part of: Unexpected consequences of cardiometabolic disease Diabetes and the Heart ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Helene Christensen

(Denmark)

2 More presentations in this session

Presentation thumbnail
SGLT2 inhibitor empagliflozin remodels pericardial fat–derived lipids-initiated ventricular ion‑channel function to reduce arrhythmogenic electrical remodeling in diabetic hearts
Doctor Y. Lin (Kaohsiung, TW)
Abstract Slides
Presentation thumbnail
Finerenone with empagliflozin according to body mass index in chronic kidney disease and type 2 diabetes
Doctor J. Ostrominski (Boston, US)
Abstract Slides

Access the full session

Session thumbnail
Unexpected consequences of cardiometabolic disease
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 14:40 CET
You may be interested in
thumbnail
Congress Presentation
Causal pathways linking type 2 diabetes and glycemic traits to cerebrovascular outcomes: a comprehensive Mendelian randomization analysis
20 March 2026
thumbnail
Congress Presentation
Upsurge in diagnosed cardiac amyloidosis: a nationwide analysis
29 June 2021
thumbnail
Congress Presentation
The impact of age of onset and duration of Type 2 diabetes on life expectancy and serious health outcomes
1 September 2025
thumbnail
Congress Presentation
Twenty-year trends in peripheral artery disease, lower extremity revascularization, and lower extremity amputation in newly diagnosed type 2 diabetes
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources